Chondropsin-class antitumor V-ATPase inhibitor compounds, compositions and methods of use thereof

Details for Australian Patent Application No. 2003269924 (hide)

Owner The Government of the United States of America, Represented by The Secretary, Dept. of Health and Human Services

Inventors Boyd, Michael R.; Gustafson, Kirk R.

Agent Fisher Adams Kelly

Pub. Number AU-B-2003269924

PCT Number PCT/US03/23290

PCT Pub. Number WO2004/009079

Priority 60/398,092 24.07.02 US

Filing date 24 July 2003

Wipo publication date 9 February 2004

Acceptance publication date 24 January 2008

International Classifications

C07D 309/06 (2006.01) Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings

C07D 498/08 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

15 January 2004 Complete Application Filed

  Priority application(s): 60/398,092 24.07.02 US

18 March 2004 Application Open to Public Inspection

  Published as AU-B-2003269924

19 May 2005 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 04 Feb 2005

24 January 2008 Application Accepted

  Published as AU-B-2003269924

22 May 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003269925-A SYSTEM AND METHOD FOR DETERMINING PHYSICAL LOCATION OF A NODE IN A WIRELESS NETWORK DURING AN AUTHENTICATION CHECK OF THE NODE

2003269923-MORPHOLINE DERIVATIVES